Are patients with potential celiac disease really potential? the answer of metabonomics

Journal of Proteome Research

Volumn 10, Issue 2, 2011, Pages 714-721

  Bernini, Patrizia ^a,b   Bertini, Ivano ^a   Calabro, Antonio ^a,c   La Marca, Giancarlo ^a,d   Lami, Gabriele ^a   Luchinat, Claudio ^a   Renzi, Daniela ^a,c   Tenori, Leonardo ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b FiorGen Foundation   (Italy)

^c Tuscany Referral Center for Adult Celiac Disease   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Metabolomics; Metabonomics; Nuclear magnetic resonance; Potential celiac disease

Indexed keywords

ACETOACETIC ACID; ARGININE; CHOLINE; CITRIC ACID; CITRULLINE; CREATININE; DIMETHYLGLYCINE; GLUCOSE; GLUTAMIC ACID; HIPPURIC ACID; INDICAN; ISOLEUCINE; LACTIC ACID; LEUCINE; METHIONINE; METHYLAMINE; PHENYLALANINE; PROLINE; SARCOSINE; SERINE; VALERIC ACID; VALINE;

ADULT; ARTICLE; CELIAC DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HUMAN; INTESTINE VILLUS ATROPHY; MAJOR CLINICAL STUDY; MALE; METABOLOME; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SERUM; URINE;

ADULT; ALGORITHMS; CASE-CONTROL STUDIES; CELIAC DISEASE; CITRULLINE; CLUSTER ANALYSIS; FEMALE; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; MODELS, STATISTICAL; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; REPRODUCIBILITY OF RESULTS;

EID: 79955425273     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100896s     Document Type: Article

References (44)

1. Kagnoff, M. F. Celiac disease: pathogenesis of a model immunogenetic disease. J. Clin. Invest. 2007, 117, 41-49. (Pubitemid 46048448)
2. Trier, J. S. Celiac sprue. N. Engl. J. Med. 1991, 325, 1709-1719.
3. Schuppan, D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000, 119, 234-242. (Pubitemid 30452598)
4. Farrell, R. J.; Kelly, C. P. Celiac sprue. N. Engl. J. Med. 2002, 346, 180-188. (Pubitemid 34438885)
5. Green, P. H.; Jabri, B. Coeliac disease. Lancet 2003, 362, 383-391. (Pubitemid 36945070)
6. Green, P. H.; Cellier, C. Celiac disease. N. Engl. J. Med. 2007, 357, 1731-1743.
7. Di Sabatino, A.; Corazza, G. R. Coeliac disease. Lancet 2009, 373, 1480-1493.
8. Troncone, R.; Auricchio, R.; Granata, V. Issues related to glutenfree diet in coeliac disease. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11, 329-333. (Pubitemid 351533910)
9. Setty, M.; Hormaza, L.; Guandalini, S. Celiac disease: risk assessment, diagnosis, and monitoring. Mol. Diagn. Ther. 2008, 12, 289-298.
10. Kaukinen, K.; Mäki, M.; Partanen, J.; Sievanen, H.; Collin, P. Celiac disease without villous atrophy. Revision of criteria called for. Dig. Dis. Sci. 2001, 46, 879-887. (Pubitemid 32373111)
11. Kaukinen, K.; Peräaho, M.; Collin, P.; Partanen, J.; Woolley, N.; Kaartinen, T.; Nuutinen, T.; Halttunen, T.; Mäki, M.; Korponay-Szabo, I. Small bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized study. Scand. J. Gastroenterol. 2005, 40, 564-572. (Pubitemid 40676250)
12. Troncone, R. Latent coeliac disease in Italy. Acta Paediatr. 1995, 84, 1252-7.
13. Matysiak-Budnik, T.; Malamut, G.; de Serre, N. P.; Grosdidier, E.; Seguier, S.; Brousse, N.; Caillat-Zucman, S.; Cerf-Bensussan, N.; Schmitz, J.; Cellier, C. Long-term follow-up of 61 patients diagnosed in childhood: evolution towards latency is possible on a normal diet. Gut 2007, 56, 1379-86. (Pubitemid 47517831)
14. Bertini, I.; Calabrò, A.; De Carli, V.; Luchinat, C.; Nepi, S.; Porfirio, B.; Renzi, D.; Saccenti, E.; Tenori, L. The metabonomic signature of celiac disease. J. Proteome Res. 2009, 8, 170-177.
15. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29, 1181-1189.
16. Fasano, A.; Catassi, C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001, 12, 1527-1528.
17. Jackson Allen, P. L. Guidelines for the diagnosis and treatment of celiac disease in children. Pediatr. Nurs. 2004, 30, 473-476.
18. Cellier, C.; Green, P. H.; Collin, P.; Murray, J. ICCE consensus for celiac disease. Endoscopy 2005, 37, 1055-1059. (Pubitemid 41489288)
19. Hill, I. D.; Dirks, M. H.; Liptak, G. S.; Colletti, R. B.; Fasano, A.; Guandalini, S.; Hoffenberg, E. J.; Horvath, K.; Murray, J. A.; Pivor, M.; Seidman, E. G. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J. Pediatr. Gastroenterol. Nutr. 2005, 40,1-19. (Pubitemid 40180049)
20. Ferguson, A.; Arranz, E.; O'Mahony, S. Clinical and pathological spectrum of coeliac disease: active, silent, latent and potential. Gut 1993, 34, 150-151. (Pubitemid 23049101)
21. Troncone, R.; Greco, L.; Mayer, M.; Paparo, M.; Caputo, N.; Micillo, M.; Mugione, P.; Auricchio, S. Latent and potential coeliac disease. Acta Paediatr. Supp. 1996, 1412, 10-14. (Pubitemid 26191734)
22. Kurppa, K.; Ashorn, M.; Iltanen, S.; Koskinen, L. L.; Saavalainen, P.; Koskinen, O.; Mäki, M.; Kaukinen, K. Celiac disease without villous atrophy in children: a prospective study. J. Pediatr. 2010, 157 (3), 373-380.
23. Kurppa, K.; Collin, P.; Viljamaa, M.; Haimila, K.; Saavalainen, P.; Partanen, J.; Laurila, K.; Huhtala, H.; Paasikivi, K.; Mäki, M.; Kaukinen, K. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009, 136 (3), 816-823.
24. Tosco, A.; Salvati, V. M.; Auricchio, R.; Maglio, M.; Borrelli, M.; Corazzo, A.; Paparo, F.; Beffardi, M.; Esposito, A.; D'Adamo, G.; Malamisura, B.; Greco, L.; Troncone, R. Most children with potential celiac disease are healthy but 1 third of them develop villous atrophy at 3-years follow-up Clin. Gastroenterol. Hepatol. [Online early access]. DOI: 10.1016/j.cgh.2010.09.006. Published online: Sept 17, 2010.
25. Oberhuber, G.; Granditsch, G.; Vogelsang, H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur. J. Gastroenterol. Hepatol. 1999, 11, 1185-1194. (Pubitemid 30433773)
26. Matà, S.; Renzi, D.; Pinto, F.; Calabrò, A. Anti-tissue transglutaminase IgA antibodies in peripheral neuropathy and motor neuronopathy. Acta Neurol. Scand. 2006, 114, 54-58. (Pubitemid 43873525)
27. Rantalainen, M.; Bylesjö, M.; Cloarec, O.; Nicholson, J. K.; Holmes, E. ; Trygg, J. Kernel-based orthogonal projections to latent structures (K-OPLS). J. Chemom. 2007, 21, 376-385.
28. Bylesjö, M.; Rantalainen, M.; Nicholson, J. K.; Holmes, E.; Trygg, J. K-OPLS package: kernel-based orthogonal projections to latent structures for prediction and interpretation in feature space. BMC Bioinf. 2008, 9, 106-110.
29. Vapnik, V. N. The Nature of Statistical Learning Theory; Springer-Verlag: New York, 1995.
30. Chang C.-C.; Lin, C.-J.; LIBSVM: a Library for Support Vector Machines, 2001. Software available at http://www.csie.ntu.edu.tw/~cjlin/libsvm.
31. Westerhuis, J. A.; Hoefsloot, H. C. J.; Smit, S.; Vis, D. J.; Smilze, A. K.; van Velzen, E. J. J.; van Duijnhoven, J. P. M.; van Dorsten, F. A. Assessment of PLSDA cross validation. Metabolomics 2008, 4, 81-89. (Pubitemid 351217591)
32. Ihaka, R.; Gentleman, R. R: A language for data analysis and graphic. J. Comput. Stat. Graph. 1996, 5, 299-314.
33. Crenn, P.; Coudray-Lucas, C.; Thuillier, F.; Cynober, L.; Messing, B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000, 119, 1496-505. (Pubitemid 32198675)
34. Crenn, P.; Vahedi, K.; Lavergne-Slove, A.; Cynober, L.; Matuchansky, C.; Messing, B. Plasma citrulline: a marker ofenterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003, 124, 1210-1219. (Pubitemid 36531797)
35. Blijlevens, N. M.; Lutgens, L. C.; Schattenberg, A. V.; Donnelly, J. P. Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant. 2004, 34, 193-196. (Pubitemid 39136824)
36. Pappas, P. A.; Tzakis, A. G.; Saudubray, J. M. Trends in serum citrulline and acute rejection among recipients of small bowel transplants. Transplant Proc. 2004, 36, 345-347. (Pubitemid 38407190)
37. Miceli, E.; Poggi, N.; Missanelli, A.; Bianchi, P.; Moratti, R.; Corazza, G. R. Is serum citrulline measurement clinically useful in coeliac disease. Intern. Emerg. Med. 2008, 3, 233-236.
38. Sollid, M. L.; Gray, G. M. A role for bacteria in celiac disease. Am. J. Gastroenterol. 2004, 99, 894-904.
39. Schippa, S.; Iebba, V.; Barbato, M.; di Nardo, G.; Totino, V.; Proietti Checchi, M.; Longhi, C.; Maiella, G.; Cucchiara, S.; Conte, M. P. A distinctive 'microbial signature' in celiac pediatric patients. BMC Microbiol. 2010, 10, 175.
40. Windmueller, H. G.; Spaeth, A. E. Source and fate of circulating citrulline. Am. J. Physiol. 1981, 241, 473-480. (Pubitemid 12207958)
41. Wakabayashi, Y.; Jones, M. E. Pyrroline-5-carboxylate synthesis from glutamate by rat intestinal mucosa. J. Biol. Chem. 1983, 258, 3865-3872. (Pubitemid 13052878)
42. Wu, G. Intestinal mucosal amino acid catabolism. J. Nutr. 1998, 128, 1249-1252.
43. Wakabayashi, Y.; Yamada, E.; Hasegawa, T.; Yamada, R. Enzymological evidence for the indispensability of small intestine in the synthesis of arginine from glutamate.I. Pyrroline-5-carboxylate synthase. Arch. Biochem. Biophys. 1991, 291, 1-8.
44. Crenn, P.; Messing, B.; Cynober, L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr. 2008, 27, 328-339.